13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001104659-24-118283
Total Value
$123.5M
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 135,400 | $15.5M | 12.53% |
| 2 | OCULAR THERAPEUTIX INC | OCUL | 1,190,071 | $10.4M | 8.39% |
| 3 | TOURMALINE BIO INC | 89157D105 | 332,095 | $8.5M | 6.92% |
| 4 | INSMED INC | INSM | 107,500 | $7.8M | 6.36% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 296,368 | $7.6M | 6.13% |
| 6 | CRINETICS PHARMACEUTICALS IN | CRNX | 131,700 | $6.7M | 5.45% |
| 7 | ARCELLX INC | ACLX | 62,100 | $5.2M | 4.20% |
| 8 | MEREO BIOPHARMA GROUP PLC | MREO | 1,260,700 | $5.2M | 4.20% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 108,000 | $4.9M | 3.97% |
| 10 | TAYSHA GENE THERAPIES INC | TSHA | 2,118,992 | $4.3M | 3.45% |
| 11 | TERNS PHARMACEUTICALS INC | TERN | 487,000 | $4.1M | 3.29% |
| 12 | KURA ONCOLOGY INC. COMMON STOCK | KURA | 197,000 | $3.8M | 3.12% |
| 13 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $3.8M | 3.09% |
| 14 | ROCKET PHARMACEUTICALS INC | RCKTW | 190,000 | $3.5M | 2.84% |
| 15 | PRAXIS PRECISION MEDICINES I | PRAX | 57,500 | $3.3M | 2.68% |
| 16 | ARGENX SE | ARGX | 5,900 | $3.2M | 2.59% |
| 17 | ASCENDIS PHARMA A/S | ASND | 21,000 | $3.1M | 2.54% |
| 18 | COMPASS PATHWAYS PLC | CMPS | 386,500 | $2.4M | 1.97% |
| 19 | MERSANA THERAPEUTICS INC | 59045L106 | 1,200,000 | $2.3M | 1.84% |
| 20 | HELIX ACQUISITION CORP II | HLXC | 180,945 | $1.9M | 1.53% |
| 21 | ACELYRIN INC | 00445A100 | 364,000 | $1.8M | 1.45% |
| 22 | EDGEWISE THERAPEUTICS INC | EWTX | 63,000 | $1.7M | 1.36% |
| 23 | DYNE THERAPEUTICS INC | DYN | 46,200 | $1.7M | 1.34% |
| 24 | GILEAD SCIENCES INC | GILD | 19,500 | $1.6M | 1.32% |
| 25 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 25,100 | $1.4M | 1.13% |
| 26 | TREVI THERAPEUTICS INC | TRVI | 290,500 | $970,270 | 0.79% |
| 27 | UNICYCIVE THERAPEUTICS INC | UNCY | 1,979,199 | $807,315 | 0.65% |
| 28 | LIQUIDIA CORPORATION | LQDA | 73,500 | $735,000 | 0.60% |
| 29 | VERVE THERAPEUTICS INC | 92539P101 | 146,100 | $707,124 | 0.57% |
| 30 | GERON CORP | GERN | 154,900 | $703,246 | 0.57% |
| 31 | CELCUITY INC | CELC | 46,600 | $694,806 | 0.56% |
| 32 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 44,000 | $679,800 | 0.55% |
| 33 | TECTONIC THERAPEUTIC INC | TECX | 13,700 | $415,110 | 0.34% |
| 34 | CORBUS PHARMACEUTICALS HOLDINGS | CRBP | 18,500 | $381,655 | 0.31% |
| 35 | RAPPORT THERAPEUTICS INC | RAPP | 17,600 | $360,448 | 0.29% |
| 36 | LEAP THERAPEUTICS INC | CYPH | 120,500 | $309,685 | 0.25% |
| 37 | CLIMB BIO INC | CLYM | 54,000 | $274,860 | 0.22% |
| 38 | BENITEC BIOPHARMA INC | BNTC | 29,800 | $273,862 | 0.22% |
| 39 | TRAVERE THERAPEUTICS INC | TVTX | 19,000 | $265,810 | 0.22% |
| 40 | THIRD HARMONIC BIO INC | 88427A107 | 15,508 | $210,133 | 0.17% |
| 41 | NUVATION BIO INC -CW27 | NUVB | 90,832 | $8,892 | 0.01% |